Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.

Parr DG, Lara B.

Drug Des Devel Ther. 2017 Jul 14;11:2149-2162. doi: 10.2147/DDDT.S105207. eCollection 2017. Review.

2.

Quantifying the Lung at Risk in Chronic Obstructive Pulmonary Disease. Does Emphysema Beget Emphysema?

Parr DG.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):535-536. doi: 10.1164/rccm.201705-0962ED. No abstract available.

PMID:
28609633
3.

Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.

Subramanian DR, Gupta S, Burggraf D, Vom Silberberg SJ, Heimbeck I, Heiss-Neumann MS, Haeussinger K, Newby C, Hargadon B, Raj V, Singh D, Kolsum U, Hofer TP, Al-Shair K, Luetzen N, Prasse A, Müller-Quernheim J, Benea G, Leprotti S, Boschetto P, Gorecka D, Nowinski A, Oniszh K, Castell WZ, Hagen M, Barta I, Döme B, Strausz J, Greulich T, Vogelmeier C, Koczulla AR, Gut I, Hohlfeld J, Welte T, Lavae-Mokhtari M, Ziegler-Heitbrock L, Brightling C, Parr DG.

Eur Respir J. 2016 Jul;48(1):92-103. doi: 10.1183/13993003.01878-2015. Epub 2016 May 26.

4.

Lung density associates with survival in alpha 1 antitrypsin deficient patients.

Green CE, Parr DG, Edgar RG, Stockley RA, Turner AM.

Respir Med. 2016 Mar;112:81-7. doi: 10.1016/j.rmed.2016.01.007. Epub 2016 Jan 22.

5.

Prevalence and radiological outcomes of lung nodules in alpha 1-antitrypsin deficiency.

Subramanian DR, Edgar R, Ward H, Parr DG, Stockley RA.

Respir Med. 2013 Jun;107(6):863-9. doi: 10.1016/j.rmed.2012.12.021. Epub 2013 Jan 20.

6.

Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography.

Subramanian DR, Jenkins L, Edgar R, Quraishi N, Stockley RA, Parr DG.

Am J Respir Crit Care Med. 2012 Dec 1;186(11):1125-32. doi: 10.1164/rccm.201201-0051OC. Epub 2012 Jul 26.

PMID:
22837375
7.

Patient phenotyping and early disease detection in chronic obstructive pulmonary disease.

Parr DG.

Proc Am Thorac Soc. 2011 Aug;8(4):338-49. doi: 10.1513/pats.201101-014RM. Review.

PMID:
21816990
8.
9.

Studies of gamma-glutamyl transferase in alpha-1 antitrypsin deficiency.

Holme J, Dawkins PA, Stockley EK, Parr DG, Stockley RA.

COPD. 2010 Apr;7(2):126-32. doi: 10.3109/15412551003631733.

PMID:
20397813
10.

Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.

Parr DG, Dirksen A, Piitulainen E, Deng C, Wencker M, Stockley RA.

Respir Res. 2009 Aug 13;10:75. doi: 10.1186/1465-9921-10-75.

11.

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.

Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA.

Eur Respir J. 2009 Jun;33(6):1345-53. doi: 10.1183/09031936.00159408. Epub 2009 Feb 5.

12.

Can the extent of low-attenuation areas on CT scans really demonstrate changes in the severity of emphysema?

Stoel BC, Parr DG, Bakker EM, Putter H, Stolk J, Gietema HA, Schilham AM, van Ginneken B, van Klaveren RJ, Lammers JW, Prokop M.

Radiology. 2008 Apr;247(1):293-4; author reply 294. doi: 10.1148/radiol.2471071608. No abstract available.

PMID:
18372475
13.

Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances.

Parr DG, Sevenoaks M, Deng C, Stoel BC, Stockley RA.

Respir Res. 2008 Feb 13;9:21. doi: 10.1186/1465-9921-9-21.

14.

Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.

Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA.

Am J Respir Crit Care Med. 2007 Dec 15;176(12):1215-21. Epub 2007 Sep 13.

PMID:
17872489
15.

Progression parameters for emphysema: a clinical investigation.

Stolk J, Putter H, Bakker EM, Shaker SB, Parr DG, Piitulainen E, Russi EW, Grebski E, Dirksen A, Stockley RA, Reiber JH, Stoel BC.

Respir Med. 2007 Sep;101(9):1924-30. Epub 2007 Jul 20.

16.

Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study.

Parr DG, White AJ, Bayley DL, Guest PJ, Stockley RA.

Respir Res. 2006 Nov 18;7:136.

17.

Computed tomography: a new gold standard for the clinical assessment of emphysema.

Parr DG, Dawkins PA, Stockley RA.

Am J Respir Crit Care Med. 2006 Oct 15;174(8):954; author reply 954-5. No abstract available.

PMID:
17021361
18.

Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.

Parr DG, Stoel BC, Stolk J, Stockley RA.

Thorax. 2006 Jun;61(6):485-90. Epub 2006 Mar 14.

19.

Variability in densitometric assessment of pulmonary emphysema with computed tomography.

Bakker ME, Stolk J, Putter H, Shaker SB, Parr DG, Piitulainen E, Russi EW, Dirksen A, Stockley RA, Reiber JH, Stoel BC.

Invest Radiol. 2005 Dec;40(12):777-83.

PMID:
16304481
20.

Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment.

Parr DG, Stoel BC, Stolk J, Stockley RA.

Am J Respir Crit Care Med. 2004 Dec 1;170(11):1172-8. Epub 2004 Aug 11.

PMID:
15306534
21.

Influence of calibration on densitometric studies of emphysema progression using computed tomography.

Parr DG, Stoel BC, Stolk J, Nightingale PG, Stockley RA.

Am J Respir Crit Care Med. 2004 Oct 15;170(8):883-90. Epub 2004 Jul 21.

PMID:
15271692
22.

Standardization of CT densitometry.

Parr DG, Stockley RA.

Radiology. 2004 Mar;230(3):887; author reply 887. No abstract available.

PMID:
14990850
23.

Panniculitis secondary to extravasation of clarithromycin in a patient with alpha 1-antitrypsin deficiency (phenotype PiZ).

Parr DG, Stewart DG, Hero I, Stockley RA.

Br J Dermatol. 2003 Aug;149(2):410-3.

PMID:
12932253
24.

Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin.

Lim AY, Parr DG, Stableforth DE, Fellows M, Fontaine R, Fegan CD.

Eur J Intern Med. 2003 Mar;14(2):89-93.

PMID:
12719024

Supplemental Content

Support Center